发明名称 |
Use of SPLA2 activity for the diagnosis of a cardiovascular event |
摘要 |
The present invention relates a method for determining an increased risk of mortality or of a cardiac and/or vascular event in a patient, comprising: - determining the sPLA2 activity of said patient as a first risk marker - determining at least the value of a second risk marker chosen among CRP level, IgM IC of apo B 100 level or IgM MDA-LDL level - determining the ratio (odds ratio) between the value of the sPLA2 activity and the value of the second risk marker and comparing it to a predetermined odds ratio, said odds ratio compared to said predetermined odds ratio being indicative of an increased risk of mortality or of a cardiac and /or vascular event. The present invention further relates a new micro method adaptation for automated fluorimetric measurement of serum secretory phospholipase A2.
|
申请公布号 |
EP2360268(A1) |
申请公布日期 |
2011.08.24 |
申请号 |
EP20100180569 |
申请日期 |
2007.07.31 |
申请人 |
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) |
发明人 |
TEDGUI, ALAIN;MALLAT, ZIAD;BENESSIANO, JOELLE |
分类号 |
C12Q1/44;G01N33/573 |
主分类号 |
C12Q1/44 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|